236 related articles for article (PubMed ID: 12795454)
21. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
22. Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing.
Steward DL
Laryngoscope; 2004 Sep; 114(9):1525-8. PubMed ID: 15475774
[TBL] [Abstract][Full Text] [Related]
23. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
Richter JE; Bochenek W
Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
[TBL] [Abstract][Full Text] [Related]
24. Extraesophageal manifestations of GERD: diagnosis and therapy.
Halstead LA
Drugs Today (Barc); 2005 Jul; 41 Suppl B():19-26. PubMed ID: 16200228
[TBL] [Abstract][Full Text] [Related]
25. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
26. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
Orr WC
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):113-20. PubMed ID: 15647651
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T
Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
[TBL] [Abstract][Full Text] [Related]
28. Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.
Calabrese C; Fabbri A; Areni A; Scialpi C; Zahlane D; Di Febo G
World J Gastroenterol; 2005 Dec; 11(48):7657-60. PubMed ID: 16437694
[TBL] [Abstract][Full Text] [Related]
29. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
Pratha V; Hogan DL; Lynn RB; Field B; Metz DC
Dig Dis Sci; 2006 Sep; 51(9):1595-601. PubMed ID: 16927137
[TBL] [Abstract][Full Text] [Related]
30. Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease.
Plein K; Hotz J; Wurzer H; Fumagalli I; Lühmann R; Schneider A
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):425-32. PubMed ID: 10783996
[TBL] [Abstract][Full Text] [Related]
31. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.
Armstrong D; Kazim F; Gervais M; Pyzyk M
Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723
[TBL] [Abstract][Full Text] [Related]
32. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of controloc in the treatment of acid-dependent diseases].
Chubenko SS; Gaĭdukov VO; Agibalov AN; Onishenko AV
Lik Sprava; 2003 Dec; (8):103-4. PubMed ID: 14965022
[TBL] [Abstract][Full Text] [Related]
34. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Bochenek WJ; Mack ME; Fraga PD; Metz DC
Aliment Pharmacol Ther; 2004 Nov; 20(10):1105-14. PubMed ID: 15569113
[TBL] [Abstract][Full Text] [Related]
35. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
Escourrou J; Deprez P; Saggioro A; Geldof H; Fischer R; Maier C
Aliment Pharmacol Ther; 1999 Nov; 13(11):1481-91. PubMed ID: 10571605
[TBL] [Abstract][Full Text] [Related]
36. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
Talley NJ; Moore MG; Sprogis A; Katelaris P
Med J Aust; 2002 Oct; 177(8):423-7. PubMed ID: 12381251
[TBL] [Abstract][Full Text] [Related]
37. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
Röhss K; Lind T; Wilder-Smith C
Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
[TBL] [Abstract][Full Text] [Related]
38. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole.
Pilotto A; Leandro G; Franceschi M;
Aliment Pharmacol Ther; 2003 Jun; 17(11):1399-406. PubMed ID: 12786634
[TBL] [Abstract][Full Text] [Related]
39. Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results.
Karoui S; Bibani N; Sahtout S; Zouiten L; Kallel L; Matri S; Serghini M; Ben Mustapha N; Boubaker J; Besbes G; Filali A
Dis Esophagus; 2010 May; 23(4):290-5. PubMed ID: 20002704
[TBL] [Abstract][Full Text] [Related]
40. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
